ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION
Published: 27/09/21, 08:23am (AEST)•2 pages